Literature DB >> 9716046

Suboptimal analysis using 'optimal' cutpoints.

D G Altman.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9716046      PMCID： PMC2063091          DOI： 10.1038/bjc.1998.537

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  8 in total

1.  Why do so many prognostic factors fail to pan out?

Authors:  S G Hilsenbeck; G M Clark; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  A simulation study of cross-validation for selecting an optimal cutpoint in univariate survival analysis.

Authors:  D Faraggi; R Simon
Journal:  Stat Med       Date:  1996-10-30       Impact factor: 2.373

Review 3.  Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.

Authors:  D G Altman; B Lausen; W Sauerbrei; M Schumacher
Journal:  J Natl Cancer Inst       Date:  1994-06-01       Impact factor: 13.506

4.  Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer.

Authors:  P M Ravdin; A K Tandon; D C Allred; G M Clark; S A Fuqua; S H Hilsenbeck; G C Chamness; C K Osborne
Journal:  J Clin Oncol       Date:  1994-03       Impact factor: 44.544

Review 5.  Statistical aspects of prognostic factor studies in oncology.

Authors:  R Simon; D G Altman
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

6.  Flow cytometric S-phase fraction in soft-tissue sarcoma: prognostic importance analysed in 160 patients.

Authors:  P Gustafson; M Fernö; M Akerman; B Baldetorp; H Willén; D Killander; A Rydholm
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis.

Authors:  G Ferrandina; G Scambia; F Bardelli; P Benedetti Panici; S Mancuso; A Messori
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 8.  Review of survival analyses published in cancer journals.

Authors:  D G Altman; B L De Stavola; S B Love; K A Stepniewska
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640
  8 in total
  8 in total

1.  Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer.

Authors:  Fabien Gueugnon; Aurélia Barascu; Konstantinos Mavridis; Agnès Petit-Courty; Sylvain Marchand-Adam; Valérie Gissot; Andreas Scorilas; Serge Guyetant; Yves Courty
Journal:  Tumour Biol       Date:  2015-02-13

2.  Optimal partitioning for the proportional hazards model.

Authors:  Usha Govindarajulu; Thaddeus Tarpey
Journal:  J Appl Stat       Date:  2020-11-18       Impact factor: 1.416

Review 3.  Publication of tumor marker research results: the necessity for complete and transparent reporting.

Authors:  Lisa M McShane; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

4.  Regression calibration for dichotomized mismeasured predictors.

Authors:  Loki Natarajan
Journal:  Int J Biostat       Date:  2009       Impact factor: 0.968

5.  Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer -what has gone wrong? A blueprint for the way forward in biomarker studies.

Authors:  F Huber; M Montani; T Sulser; R Jaggi; P Wild; H Moch; H Gevensleben; M Schmid; S Wyder; G Kristiansen
Journal:  Br J Cancer       Date:  2014-11-25       Impact factor: 7.640

6.  Integrative analyses of transcriptome sequencing identify novel functional lncRNAs in esophageal squamous cell carcinoma.

Authors:  C-Q Li; G-W Huang; Z-Y Wu; Y-J Xu; X-C Li; Y-J Xue; Y Zhu; J-M Zhao; M Li; J Zhang; J-Y Wu; F Lei; Q-Y Wang; S Li; C-P Zheng; B Ai; Z-D Tang; C-C Feng; L-D Liao; S-H Wang; J-H Shen; Y-J Liu; X-F Bai; J-Z He; H-H Cao; B-L Wu; M-R Wang; D-C Lin; H P Koeffler; L-D Wang; X Li; E-M Li; L-Y Xu
Journal:  Oncogenesis       Date:  2017-02-13       Impact factor: 7.485

7.  ITGB4 is a novel prognostic factor in colon cancer.

Authors:  Meng Li; Xia Jiang; Guiqi Wang; Congjie Zhai; Ying Liu; Hongyan Li; Yan Zhang; Weifang Yu; Zengren Zhao
Journal:  J Cancer       Date:  2019-08-28       Impact factor: 4.207

Review 8.  Survival analysis part IV: further concepts and methods in survival analysis.

Authors:  T G Clark; M J Bradburn; S B Love; D G Altman
Journal:  Br J Cancer       Date:  2003-09-01       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.